Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
life sciences & biomedicine (120) 120
science & technology (120) 120
humans (114) 114
female (93) 93
male (93) 93
cardiovascular (82) 82
middle aged (57) 57
ezetimibe (51) 51
aged (49) 49
biological and medical sciences (49) 49
abridged index medicus (47) 47
medical sciences (46) 46
cholesterol (42) 42
cholesterol, ldl - blood (42) 42
cardiovascular system & cardiology (39) 39
treatment outcome (39) 39
cardiac & cardiovascular systems (37) 37
double-blind method (35) 35
drug therapy, combination (35) 35
risk factors (35) 35
anticholesteremic agents - therapeutic use (31) 31
adolescent (30) 30
statins (30) 30
adult (28) 28
child (27) 27
hypercholesterolemia - drug therapy (27) 27
azetidines - therapeutic use (26) 26
lipids (26) 26
low density lipoproteins (25) 25
metabolic diseases (25) 25
cardiovascular disease (24) 24
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (23) 23
hypercholesterolemia (23) 23
simvastatin - therapeutic use (23) 23
drug therapy (22) 22
azetidines - administration & dosage (21) 21
nutrition & dietetics (20) 20
anticholesteremic agents - administration & dosage (19) 19
atorvastatin calcium (18) 18
child, preschool (18) 18
hypercholesterolemia - blood (18) 18
pharmacology & pharmacy (18) 18
simvastatin (18) 18
children (17) 17
coronary heart disease (17) 17
disorders of blood lipids. hyperlipoproteinemia (17) 17
simvastatin - administration & dosage (17) 17
statin (17) 17
time factors (17) 17
cardiology. vascular system (16) 16
care and treatment (16) 16
diabetes (16) 16
health aspects (16) 16
analysis (14) 14
peripheral vascular disease (14) 14
atorvastatin (13) 13
general & internal medicine (13) 13
heptanoic acids - therapeutic use (13) 13
internal medicine (13) 13
ldl-c (13) 13
medicine, general & internal (13) 13
pyrroles - therapeutic use (13) 13
biomarkers - blood (12) 12
cardiovascular diseases (12) 12
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (12) 12
hypercholesterolemia - complications (12) 12
low density lipoprotein (12) 12
pediatrics (12) 12
research (12) 12
antilipemic agents (11) 11
cardiology (11) 11
children & youth (11) 11
lipids - blood (11) 11
nutrition (11) 11
retrospective studies (11) 11
acute coronary syndrome - drug therapy (10) 10
aged, 80 and over (10) 10
clinical trials (10) 10
dosage and administration (10) 10
dose-response relationship, drug (10) 10
heptanoic acids - administration & dosage (10) 10
medicine, research & experimental (10) 10
pyrroles - administration & dosage (10) 10
research & experimental medicine (10) 10
young adult (10) 10
biochemistry & molecular biology (9) 9
cardiology and cardiovascular medicine (9) 9
cholesterol, ldl - drug effects (9) 9
drug combinations (9) 9
endocrinology & metabolism (9) 9
ezetimibe - therapeutic use (9) 9
follow-up studies (9) 9
low-density lipoprotein cholesterol (9) 9
pharmacology. drug treatments (9) 9
randomized controlled trials as topic (9) 9
studies (9) 9
sulfonamides - therapeutic use (9) 9
triglycerides (9) 9
anticholesteremic agents - adverse effects (8) 8
azetidines - adverse effects (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text On-Treatment Analysis of the Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT)
by Blazing, Michael A., MD and Giugliano, Robert P., MD, SM and de Lemos, James A., MD and Cannon, Christopher P., MD and Tonkin, Andrew, MBBS, MD and Ballantyne, Christie M., MD and Lewis, Basil S., MD and Musliner, Thomas A., MD and Tershakovec, Andrew M., MD, MPH and Lokhnygina, Yuliya, PhD and White, Jennifer A., MS and Reist, Craig, PhD and McCagg, Amy, BS and Braunwald, Eugene, MD
The American heart journal, ISSN 0002-8703, 2016, Volume 182, pp. 89 - 96
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Simvastatin - adverse effects | Ezetimibe - adverse effects | Simvastatin - administration & dosage | Humans | Middle Aged | Male | Treatment Outcome | Ezetimibe - administration & dosage | Drug Monitoring - methods | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Dose-Response Relationship, Drug | Drug Synergism | Drug Therapy, Combination - methods | Anticholesteremic Agents - administration & dosage | Acute Coronary Syndrome - diagnosis | Cholesterol, LDL - blood | Drug Therapy, Combination - statistics & numerical data | Female | Aged | Clinical trials | Coronary heart disease | Simvastatin | Analysis | Cardiovascular disease | Health risk assessment | Low density lipoprotein | Mortality | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: Final baseline characteristics of the IMPROVE-IT study population
by Blazing, Michael A., MD and Giugliano, Robert P., MD, SM and Cannon, Christopher P., MD and Musliner, Thomas A., MD and Tershakovec, Andrew M., MD, MPH and White, Jennifer A., MS and Reist, Craig, PhD and McCagg, Amy, BS and Braunwald, Eugene, MD and Califf, Robert M., MD
The American heart journal, ISSN 0002-8703, 2014, Volume 168, Issue 2, pp. 205 - 212.e1
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Simvastatin - therapeutic use | Cardiovascular Diseases - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Ezetimibe | Cholesterol, LDL - drug effects | Male | Azetidines - pharmacology | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Acute Coronary Syndrome - complications | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Cardiovascular Diseases - epidemiology | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Anticholesteremic Agents - pharmacology | Medical research | Low density lipoproteins | Simvastatin | Cardiac patients | Medicine, Experimental | Coronary heart disease | Antilipemic agents | Heart attacks | Acute coronary syndromes | Drug therapy | Cholesterol | Statins | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Pooled Analyses of Effects on C-Reactive Protein and Low Density Lipoprotein Cholesterol in Placebo-Controlled Trials of Ezetimibe Monotherapy or Ezetimibe Added to Baseline Statin Therapy
by Pearson, Thomas A., MD, PhD and Ballantyne, Christie M., MD and Veltri, Enrico, MD and Shah, Arvind, MD and Bird, Steven, MS and Lin, Jianxin, MS and Rosenberg, Elizabeth, PhD and Tershakovec, Andrew M., MD, MPH
The American journal of cardiology, ISSN 0002-9149, 2009, Volume 103, Issue 3, pp. 369 - 374
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Medical sciences | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Hypercholesterolemia - blood | Humans | Middle Aged | Ezetimibe | Male | Hypercholesterolemia - drug therapy | Randomized Controlled Trials as Topic | Azetidines - administration & dosage | Anticholesteremic Agents - administration & dosage | Cholesterol, LDL - blood | Female | C-Reactive Protein - analysis | Drug Therapy, Combination | Hypercholesterolemia | C-reactive protein | Low density lipoproteins | Clinical trials | Diabetes | Coronary heart disease | Trans fatty acids | Statins | Cholesterol | Cardiovascular agents | Cardiovascular disease | Cardiology | Drug therapy | Low density lipoprotein | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Safety and Efficacy of Ezetimibe Added on to Rosuvastatin 5 or 10 mg Versus Up-Titration of Rosuvastatin in Patients With Hypercholesterolemia (the ACTE Study)
by Bays, Harold E., MD, FACP, FACE, FNLA and Davidson, Michael H., MD, FACC, FNLA and Massaad, Rachid, MSc and Flaim, Doreen, MS and Lowe, Robert S., PhD and Tershakovec, Andrew M., MD, MPH and Jones-Burton, Charlotte, MD, MS
The American journal of cardiology, ISSN 0002-9149, 2011, Volume 108, Issue 4, pp. 523 - 530
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Metabolic diseases | Medical sciences | Disorders of blood lipids. Hyperlipoproteinemia | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Double-Blind Method | Pyrimidines - administration & dosage | Humans | Middle Aged | Ezetimibe | Rosuvastatin Calcium | Cholesterol, LDL - drug effects | Male | Treatment Outcome | Fluorobenzenes - administration & dosage | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - therapeutic use | Azetidines - administration & dosage | Azetidines - therapeutic use | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Anticholesteremic Agents - administration & dosage | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Female | Aged | Drug Therapy, Combination | Fluorobenzenes - therapeutic use | Sulfonamides - administration & dosage | Cholesterol | Cardiovascular disease | Drug therapy | Cardiology | Low density lipoprotein | Statins | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Coadministered With Extended-Release Niacin in Patients With Type IIa or Type IIb Hyperlipidemia
by Guyton, John R., MD and Brown, B. Greg, MD, PhD and Fazio, Sergio, MD, PhD and Polis, Adam, MA and Tomassini, Joanne E., PhD and Tershakovec, Andrew M., MD, MPH
Journal of the American College of Cardiology, ISSN 0735-1097, 2008, Volume 51, Issue 16, pp. 1564 - 1572
Cardiovascular | Internal Medicine | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Simvastatin - therapeutic use | Simvastatin - adverse effects | Humans | Middle Aged | Ezetimibe | Male | Niacin - administration & dosage | Niacin - therapeutic use | Lipids - blood | Niacin - adverse effects | Adult | Female | Hyperlipoproteinemia Type II - drug therapy | Drug Therapy, Combination | Hypolipidemic Agents - adverse effects | Cholesterol, HDL - drug effects | Simvastatin - administration & dosage | Azetidines - adverse effects | Cholesterol, LDL - drug effects | Apolipoproteins - drug effects | Anticholesteremic Agents - therapeutic use | Azetidines - administration & dosage | Azetidines - therapeutic use | Adolescent | Hypolipidemic Agents - administration & dosage | Hypolipidemic Agents - therapeutic use | Delayed-Action Preparations | Care and treatment | Drug therapy, Combination | Cardiology | Hyperlipidemia | Niacin | Confidence intervals | Lipoproteins | Mortality | Vitamin B | Cardiovascular disease | Lipids | Gallbladder | Triglycerides | Diabetes | Drug dosages | Patients | Cholesterol | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Efficacy and Safety of Ezetimibe Added on to Atorvastatin (40 mg) Compared With Uptitration of Atorvastatin (to 80 mg) in Hypercholesterolemic Patients at High Risk of Coronary Heart Disease
by Leiter, Lawrence A., MD and Bays, Harold, MD and Conard, Scott, MD and Bird, Steven, MS and Rubino, Joseph, MBA and Hanson, Mary E., PhD and Tomassini, Joanne E., PhD and Tershakovec, Andrew M., MD
The American journal of cardiology, ISSN 0002-9149, 2008, Volume 102, Issue 11, pp. 1495 - 1501
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | Metabolic diseases | Medical sciences | Coronary heart disease | Disorders of blood lipids. Hyperlipoproteinemia | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Ezetimibe | Male | Heptanoic Acids - adverse effects | Hypercholesterolemia - drug therapy | Coronary Artery Disease - physiopathology | Pyrroles - administration & dosage | Heptanoic Acids - administration & dosage | Pyrroles - adverse effects | Female | Drug Therapy, Combination | Pyrroles - therapeutic use | Coronary Artery Disease - etiology | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Azetidines - adverse effects | Cholesterol, LDL - drug effects | Treatment Outcome | Anticholesteremic Agents - adverse effects | Atorvastatin Calcium | Anticholesteremic Agents - therapeutic use | Azetidines - administration & dosage | Azetidines - therapeutic use | Coronary Artery Disease - diagnosis | Anticholesteremic Agents - administration & dosage | Hypercholesterolemia - complications | Hypercholesterolemia - physiopathology | Medical colleges | Hypercholesterolemia | Low density lipoproteins | Atherosclerosis | Triglycerides | Comparative analysis | Risk factors | Trans fatty acids | Cholesterol | Antilipemic agents | Drugs | Medical research | Cardiovascular disease | Pharmacology | Drug therapy | Cardiology | Low density lipoprotein | Patients | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome
by Murphy, Sabina A., MPH and Cannon, Christopher P., MD and Blazing, Michael A., MD and Giugliano, Robert P., MD and White, Jennifer A., MS and Lokhnygina, Yuliya, PhD and Reist, Craig, PhD and Im, KyungAh, PhD and Bohula, Erin A., MD, DPhil and Isaza, Daniel, MD and Lopez-Sendon, Jose, MD and Dellborg, Mikael, MD and Kher, Uma, PhD and Tershakovec, Andrew M., MD, MPH and Braunwald, Eugene, MD
Journal of the American College of Cardiology, ISSN 0735-1097, 2016, Volume 67, Issue 4, pp. 353 - 361
Cardiovascular | Internal Medicine | simvastatin | total events | ezetimibe | low-density lipoprotein cholesterol | Medical colleges | Cardiology | Coronary heart disease | Low density lipoproteins | Cardiac patients | Hypertension | Heart attacks | Sensitivity analysis | Cardiovascular disease | Lipids | Cholesterol | Confidence intervals | Variables | Body mass index | Survival analysis | Coronary vessels | Diabetes | Acute coronary syndromes | Statins
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Sustained Hypophosphatemic Effect of Once-Daily Niacin/Laropiprant in Dyslipidemic CKD Stage 3 Patients
by Ix, Joachim H., MD and Ganjoo, Prerna, MD and Tipping, Diane, MS and Tershakovec, Andrew M., MD and Bostom, Andrew G., MD, MS
American journal of kidney diseases, ISSN 0272-6386, 2011, Volume 57, Issue 6, pp. 963 - 965
Nephrology | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Kidneys | Urinary system involvement in other diseases. Miscellaneous | Nephropathies. Renovascular diseases. Renal failure | Renal failure | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Hypolipidemic Agents - adverse effects | Dyslipidemias - drug therapy | Hypophosphatemia - blood | Drug Administration Schedule | Dyslipidemias - complications | Humans | Treatment Outcome | Indoles - administration & dosage | Dose-Response Relationship, Drug | Niacin - administration & dosage | Dyslipidemias - blood | Indoles - adverse effects | Kidney Failure, Chronic - blood | Lipids - blood | Hypolipidemic Agents - administration & dosage | Kidney Failure, Chronic - complications | Niacin - adverse effects | Hypophosphatemia - chemically induced | Drug Therapy, Combination | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Safety and Efficacy of Ezetimibe Added to Atorvastatin Versus Up Titration of Atorvastatin to 40 mg in Patients ≥65 Years of Age (from the ZETia in the ELDerly [ZETELD] Study)
by Zieve, Franklin, MD, PhD and Wenger, Nanette K., MD and Ben-Yehuda, Ori, MD and Constance, Christian, MD and Bird, Steven, MS and Lee, Raymond, BS and Hanson, Mary E., PhD and Jones-Burton, Charlotte, MD, MS and Tershakovec, Andrew M., MD, MPH
The American journal of cardiology, ISSN 0002-9149, 2010, Volume 105, Issue 5, pp. 656 - 663
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Medical sciences | Hyperlipidemias - blood | Age Factors | Double-Blind Method | Humans | Hyperlipidemias - drug therapy | Middle Aged | Ezetimibe | Coronary Disease - etiology | Male | Treatment Outcome | Dose-Response Relationship, Drug | Atorvastatin Calcium | Coronary Disease - prevention & control | Azetidines - administration & dosage | Pyrroles - administration & dosage | Anticholesteremic Agents - administration & dosage | Triglycerides - blood | Heptanoic Acids - administration & dosage | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Hyperlipidemias - complications | Apolipoprotein A-I - blood | Cholesterol | Antilipemic agents | Studies | Older people | Cardiovascular disease | Lipids | Drug therapy | Low density lipoprotein | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Safety and Efficacy of Ezetimibe / Simvastatin Combination Versus Atorvastatin Alone in Adults ≥65 Years of Age With Hypercholesterolemia and With or at Moderately High/High Risk for Coronary Heart Disease (the VYTELD Study)
by Foody, JoAnne M., MD and Brown, W. Virgil, MD and Zieve, Franklin, MD, PhD and Adewale, Adeniyi J., PhD and Flaim, Doreen, MS and Lowe, Robert S., PhD and Jones-Burton, Charlotte, MD, MS and Tershakovec, Andrew M., MD, MPH
The American journal of cardiology, ISSN 0002-9149, 2010, Volume 106, Issue 9, pp. 1255 - 1263
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | Metabolic diseases | Medical sciences | Coronary heart disease | Disorders of blood lipids. Hyperlipoproteinemia | Simvastatin - therapeutic use | Heptanoic Acids - therapeutic use | Humans | Ezetimibe | Male | Hypercholesterolemia - drug therapy | Dose-Response Relationship, Drug | Pyrroles - administration & dosage | Lipids - blood | Heptanoic Acids - administration & dosage | Female | Drug Therapy, Combination | Pyrroles - therapeutic use | Double-Blind Method | Simvastatin - administration & dosage | Risk Factors | Logistic Models | Treatment Outcome | Biomarkers - blood | Atorvastatin Calcium | Coronary Disease - prevention & control | Anticholesteremic Agents - therapeutic use | Azetidines - administration & dosage | Azetidines - therapeutic use | Anticholesteremic Agents - administration & dosage | Aged | Cholesterol | Antilipemic agents | Drugs | Older people | Mortality | Cardiovascular disease | Cardiology | Low density lipoprotein | Statins | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Comparisons of Apolipoprotein B Levels Estimated by Immunoassay, Nuclear Magnetic Resonance, Vertical Auto Profile, and Non-High-Density Lipoprotein Cholesterol in Subjects With Hypertriglyceridemia (SAFARI Trial)
by Grundy, Scott M., MD, PhD and Vega, Gloria Lena, PhD and Tomassini, Joanne E., PhD and Tershakovec, Andrew M., MD, MPH
The American journal of cardiology, ISSN 0002-9149, 2011, Volume 108, Issue 1, pp. 40 - 46
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Metabolic diseases | Medical sciences | Disorders of blood lipids. Hyperlipoproteinemia | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Hypertriglyceridemia - drug therapy | Reproducibility of Results | Magnetic Resonance Spectroscopy - methods | Prognosis | Simvastatin - administration & dosage | Humans | Fenofibrate - administration & dosage | Apolipoproteins B - blood | Hypertriglyceridemia - blood | Hypolipidemic Agents - administration & dosage | Triglycerides - blood | Immunoassay - methods | Cholesterol, LDL - blood | Drug Therapy, Combination | Clinical trials | Immunoassay | Cardiology | Low density lipoprotein | Cholesterol | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Lipid-Altering Efficacy and Safety of Ezetimibe / Simvastatin Versus Atorvastatin in Patients With Hypercholesterolemia and the Metabolic Syndrome (from the VYMET Study)
by Robinson, Jennifer G., MD, MPH and Ballantyne, Christie M., MD and Grundy, Scott M., MD, PhD and Hsueh, Willa A., MD and Parving, Hans-Henrik, MD and Rosen, Jeffrey B., MD and Adewale, Adeniyi J., PhD and Polis, Adam B., MA and Tomassini, Joanne E., PhD and Tershakovec, Andrew M., MD, MPH
The American journal of cardiology, ISSN 0002-9149, 2009, Volume 103, Issue 12, pp. 1694 - 1702
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Miscellaneous | Other metabolic disorders | Biological and medical sciences | Metabolic diseases | Medical sciences | Disorders of blood lipids. Hyperlipoproteinemia | Simvastatin - therapeutic use | Follow-Up Studies | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Ezetimibe | Male | Hypercholesterolemia - drug therapy | Metabolic Syndrome - drug therapy | Dose-Response Relationship, Drug | Young Adult | Metabolic Syndrome - blood | Pyrroles - administration & dosage | Lipids - blood | Heptanoic Acids - administration & dosage | Female | Drug Therapy, Combination | Pyrroles - therapeutic use | Hypercholesterolemia - blood | Double-Blind Method | Simvastatin - administration & dosage | Treatment Outcome | Metabolic Syndrome - complications | Atorvastatin Calcium | Anticholesteremic Agents - therapeutic use | Azetidines - administration & dosage | Azetidines - therapeutic use | Anticholesteremic Agents - administration & dosage | Adolescent | Hypercholesterolemia - complications | Aged | Cholesterol | Antilipemic agents | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights